[Paradigm Lianchuang testified in court: SBF once stated that Alameda Research did not have preferential treatment in FTX] According to news on October 6, Paradigm Lianchuang Matt Huang testified in court on Thursday regarding the SBF case. Matt Huang described Paradigm’s two total investments in FTX. A process of about $278 million. Matt Huang said that he was excited by FTX’s rapid early market share growth, but he was concerned about FTX’s lack of a formal governance structure or even a board of directors. SBF has told it that Alameda Research does not have preferential treatment in FTX. In addition, Matt Huang said that Paradigm’s investment in FTX has been accrued to zero.